Development, in vitro, and in vivo assessments of PCL-gelatin-βTCP fibrous scaffolds for cardiac regeneration
The fibrous PCL-Gel-βTCP-1% scaffold showed optimal cell proliferation, blood compatibility and vascularization. These properties highlight its promise for cardiac tissue engineering.
Authors
- Hossein Eyni (ORCID: https://orcid.org/0000-0001-7152-4512)
- Mehdi Razavi (ORCID: https://orcid.org/0000-0002-3020-6187)
- Nahid Moradi (ORCID: https://orcid.org/0000-0002-0871-3975)
- Sepehr Zamani (ORCID: https://orcid.org/0000-0001-8098-1467)
- Nafiseh Baheiraei (ORCID: https://orcid.org/0000-0002-8760-5971)
- Majid Salehi (ORCID: https://orcid.org/0000-0002-0649-596X)
- Mahnaz Fathi (ORCID: https://orcid.org/0009-0003-8038-2845)
Institutions
- University of Central Florida (US)
- Tarbiat Modares University (IR)
- Iran University of Medical Sciences (IR)
- Stem Cell Technology Research Center (IR)
- Material Sciences (United States) (US)
- Shahroud University of Medical Sciences (IR)
- Florida College (US)
Publication Details
- Journal
- Bioimpacts
- Published
- 2025-08-17
- DOI
- https://doi.org/10.34172/bi.31096
- Primary Topic
- Tissue Engineering and Regenerative Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00